1.165
price down icon0.43%   -0.005
after-market アフターアワーズ: 1.15 -0.015 -1.29%
loading

Opus Genetics Inc (IRD) 最新ニュース

pulisher
Oct 25, 2024

Ocuphire Pharma Acquires Opus Genetics - Marketscreener.com

Oct 25, 2024
pulisher
Oct 25, 2024

The RD Fund Announces Ocuphire Pharma's Acquisition of Opus Genetics - StreetInsider.com

Oct 25, 2024
pulisher
Oct 24, 2024

North Carolina gains public company with merger - The Business Journals

Oct 24, 2024
pulisher
Oct 24, 2024

Ocuphire buys Opus Genetics, grows gene therapy pipeline - The Pharma Letter

Oct 24, 2024
pulisher
Oct 24, 2024

Ocuphire Pharma Announces Acquisition of Opus Genetics - Vision Monday

Oct 24, 2024
pulisher
Oct 23, 2024

Ocuphire Shares Rise After Extended US Patent For Nyxol Eye Drops Secured - Marketscreener.com

Oct 23, 2024
pulisher
Oct 23, 2024

Ocuphire Pharma Merges with Opus Genetics, Renamed Opus Genetics - Yahoo Finance

Oct 23, 2024
pulisher
Oct 23, 2024

Ophthalmic Biopharmaceutical Ocuphire Pharma Shifts Focus To Gene Therapy Through Opus Genetics Stock Deal - AOL

Oct 23, 2024
pulisher
Oct 23, 2024

Ocuphire and Opus Genetics merge to develop IRD gene therapy - Yahoo Finance

Oct 23, 2024
pulisher
Oct 23, 2024

Shareholder Alert: Ademi LLP Investigates Whether Ocuphire Pharma, Inc. Is Breaching Its Duties to Its Public Shareholders - Business Wire

Oct 23, 2024
pulisher
Oct 23, 2024

AAO 2024: Epimacular membranes and metamorphopsia - Ophthalmology Times

Oct 23, 2024
pulisher
Oct 23, 2024

Ocuphire Pharma acquires Opus Genetics in all-stock deal By Investing.com - Investing.com Australia

Oct 23, 2024
pulisher
Oct 22, 2024

Wilson Sonsini Advises Opus Genetics on IP Matters Related to Acquisition by Ocuphire Pharma - Wilson Sonsini

Oct 22, 2024
pulisher
Oct 22, 2024

Ocuphire Pharma acquires Opus Genetics in all-stock deal - Investing.com

Oct 22, 2024
pulisher
Oct 22, 2024

Ocuphire Pharma acquires Opus Genetics - Seeking Alpha

Oct 22, 2024
pulisher
Sep 30, 2024

News in Cell and Gene Therapy for Rare Cancer Day 2024 - CGTLive™

Sep 30, 2024
pulisher
Sep 28, 2024

EyeCon 2024: Taking a multidisciplinary approach to diabetic eye care - Optometry Times

Sep 28, 2024
pulisher
Sep 24, 2024

EURETINA 2024: Aleksandra Rachitskaya, MD, FASRS, and the Vit-Buckle Society come to Barcelona - Ophthalmology Times Europe

Sep 24, 2024
pulisher
Sep 23, 2024

VEW 2024: Touring the retina with Dr. Steven Ferrucci - Optometry Times

Sep 23, 2024
pulisher
Sep 13, 2024

Barry J Byrne, MD, PhD, on Making Decisions in the Face of Rapidly Expanding Treatment Options - CGTLive™

Sep 13, 2024
pulisher
Aug 30, 2024

Latest advances in X-linked retinitis pigmentosa: Optimizing diagnosis and developments in gene therapy - Ophthalmology Times

Aug 30, 2024
pulisher
Aug 13, 2024

Ocuphire Pharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 - Marketscreener.com

Aug 13, 2024
pulisher
Aug 04, 2024

William Chou, MD, on Expanding Frontotemporal Dementia Gene Therapy to Both GRN and C9orf72 Mutations - CGTLive™

Aug 04, 2024
pulisher
Jul 25, 2024

PHOTON Results and Their Relation to DME Patients in Your Practice - Ophthalmology Times Europe

Jul 25, 2024
pulisher
Jul 23, 2024

ASRS 2024: A novel approach to myopic traction maculopathy - Ophthalmology Times Europe

Jul 23, 2024
pulisher
Jul 19, 2024

ASRS 2024: Diabetic retinopathy lesions and assessing disease severity over time - Ophthalmology Times Europe

Jul 19, 2024
pulisher
Jun 26, 2024

Vertex’s Diabetes Cell Therapy on Track to Meet Endpoint of Eliminating Severe Hypoglycemic Events - CGTLive™

Jun 26, 2024
pulisher
Jun 23, 2024

Gene Therapy Improves Body Composition in Mice Models of Obesity Alone and After Semaglutide Withdrawal - CGTLive™

Jun 23, 2024
pulisher
Jun 22, 2024

Salvador Rico, MD, PhD, on Developing Gene Regulation Therapy for Dravet Syndrome - CGTLive™

Jun 22, 2024
pulisher
Jun 20, 2024

Leigh Ramos-Platt, MD, on Sharing Experience With Gene Therapy Administration - CGTLive™

Jun 20, 2024
pulisher
Jun 19, 2024

Around the Helix: Cell and Gene Therapy Company Updates – June 19, 2024 - CGTLive™

Jun 19, 2024
pulisher
Jun 13, 2024

Omer A. Abdul Hamid, MD, on Improving Gene Therapy’s Effect and Accessibility - CGTLive™

Jun 13, 2024
pulisher
Jun 12, 2024

Around the Helix: Cell and Gene Therapy Company Updates – June 12, 2024 - CGTLive™

Jun 12, 2024
pulisher
Jun 05, 2024

Department of HealthAbu Dhabi and Opus Genetics Announce Collaboration to Advance Ground-Breaking Gene Therapy Research for Inherited Retinal Diseases - PR Newswire

Jun 05, 2024
pulisher
May 06, 2024

Intellia’s Phase 3 Clinical Trial for CRISPR-Based Gene Therapy Enrolls First Patient - CGTLive™

May 06, 2024
pulisher
Apr 25, 2024

Amit Soni, MD, on Treating the First Patient With Hemophilia A Gene Therapy in the Real-World Setting - CGTLive™

Apr 25, 2024
pulisher
Apr 02, 2024

Verve Moves on to Second Gen Cardiovascular CRISPR Therapy After Adverse Events - CGTLive™

Apr 02, 2024
pulisher
Mar 27, 2024

Vision loss's role in accessibility advocacy with Rebecca Alexander - Optometry Times

Mar 27, 2024
pulisher
Mar 26, 2024

Nanoscope Therapeutics lead candidate MCO-010 meets endpoints in RESTORE trial for retinitis pigmentosa - Modern Retina

Mar 26, 2024
pulisher
Mar 24, 2024

John A. Charlson, MD, on Afami-Cel’s Upcoming Review for Synovial Sarcoma - CGTLive™

Mar 24, 2024
pulisher
Mar 06, 2024

Frederick “Eric” Arnold, PhD, on Investigating Alternative Polyadenylation in ALS Models - CGTLive™

Mar 06, 2024
pulisher
Feb 23, 2024

Alexis Kuhn, PharmD, BCOP, on Hemoglobinopathy Gene Therapies From a Pharmacist’s Perspective - CGTLive™

Feb 23, 2024
pulisher
Feb 12, 2024

symbol__ Stock Quote Price and Forecast - CNN

Feb 12, 2024
pulisher
Feb 05, 2024

EyePod: Modifier Gene Therapy: What is it? - Ophthalmology Times

Feb 05, 2024
pulisher
Jan 16, 2024

David Shyr, MD, on Surprising Findings With CRISPR Cell Therapy Nula-Cel in Sickle Cell Disease - CGTLive™

Jan 16, 2024
pulisher
Jan 15, 2024

Passage Bio’s Gene Therapy PBFT02 Positively Impacts Biomarker Levels in Patients With Frontotemporal Dementia - CGTLive™

Jan 15, 2024
pulisher
Jan 13, 2024

Kadimastem and iTolerance Work to Bring Immunosuppression-Free Diabetes Cell Therapy to Trials - CGTLive™

Jan 13, 2024
pulisher
Jan 08, 2024

Vertex Pauses Diabetes Cell Therapy Trial After Unrelated Patient Deaths - CGTLive™

Jan 08, 2024
pulisher
Dec 12, 2023

New tools emerge for the early detection of hydroxychloroquine maculopathy - Optometry Times

Dec 12, 2023
pulisher
Nov 24, 2023

AAO 2023: Marco A. Zarbin, MD, PhD, provides analysis of the YOSEMITE and RHINE clinical trials - Ophthalmology Times Europe

Nov 24, 2023
pulisher
Nov 18, 2023

Roger Hajjar, MD, on Gene Therapy as a Novel Precision Medicine Modality in Cardiology - CGTLive™

Nov 18, 2023
pulisher
Nov 01, 2023

Krystal Biotech's Side Business: Gene-Based Aesthetics - Life Science Leader Magazine

Nov 01, 2023
pulisher
Oct 28, 2023

Islet Cell Pouch Implantation Shows Promise in Type 1 Diabetes - CGTLive™

Oct 28, 2023
pulisher
Oct 24, 2023

Artificial intelligence in eye care - Optometry Times

Oct 24, 2023
pulisher
Sep 14, 2023

Dry age-related macular degeneration: The second city of AMD - Optometry Times

Sep 14, 2023
pulisher
Aug 07, 2023

Paul Hahn, MD, PhD, shares insights on pegcetacoplan versus avacincaptad pegol in patients with geographic atrophy - Optometry Times

Aug 07, 2023
pulisher
Aug 03, 2023

ASRS 2023: Fernando Arevalo on retinal detachments associated to retinoschisis - Ophthalmology Times Europe

Aug 03, 2023
pulisher
May 15, 2023

Case report: Refractory pseudophakic cystoid macular edema during an exacerbation of scleroderma - Optometry Times

May 15, 2023
pulisher
May 12, 2023

DR:EAM study: Exploring eye drops for diabetic retinopathy - Optometry Times

May 12, 2023
pulisher
Apr 04, 2023

Jennifer Morganroth, MD, MBA, on the Importance of Preparing Clinical Resources for Genetic Medicines - CGTLive™

Apr 04, 2023
pulisher
Apr 03, 2023

Geographic atrophy, pegcetacoplan, and the future of care with Dr. Euin Cheong - Optometry Times

Apr 03, 2023
pulisher
Mar 08, 2023

No Time to Pause: Companies Abandon Lagging Cell Therapy Programs - CGTLive™

Mar 08, 2023
pulisher
Feb 15, 2023

Heart Failure iPSC-Derived Therapy Trial Doses First Patient - CGTLive™

Feb 15, 2023
pulisher
Jan 15, 2023

Study: Nanotechnology may improve gene therapy for blindness - Ophthalmology Times

Jan 15, 2023
pulisher
Dec 29, 2022

Opus Genetics acquires two gene therapy candidates from Iveric Bio - Healio

Dec 29, 2022
pulisher
Jun 14, 2022

Clinical Hold Lifted on Homology’s pheNIX Trial for Phenylketonuria - CGTLive™

Jun 14, 2022
pulisher
May 23, 2022

Carsten Bönnemann, MD, on Identifying At-Risk Genotypes for DMD Gene Therapy - CGTLive™

May 23, 2022
pulisher
Feb 12, 2022

Portal extension trial: PDS maintains visual and anatomic benefits over long term - Ophthalmology Times Europe

Feb 12, 2022
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
大文字化:     |  ボリューム (24 時間):